Development and validation of cuproptosis-related gene signature in the prognostic prediction of liver cancer.

Liu, Yanqing; Liu, Yang; Ye, Shujun; Feng, Huijin; Ma, Lianjun

Liu, Yanqing; Liu, Yang; Ye, Shujun; Feng, Huijin; Ma, Lianjun.

Affiliation

Liu Y; Endoscopy Center, China-Japan Union Hospital of Jilin University, Changchun, China.
Liu Y; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, United States.
Ye S; Endoscopy Center, China-Japan Union Hospital of Jilin University, Changchun, China.
Feng H; Endoscopy Center, China-Japan Union Hospital of Jilin University, Changchun, China.
Ma L; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, United States.

Front Oncol ; 12: 985484, 2022.

Article de En | MEDLINE | ID: mdl-36033443

Mots clés

cuproptosis; liver cancer; lncRNA; mRNA; prognostic model

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: Front Oncol Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google